Jacinda Abdul-Mutakabbir, PharmD

Assistant Professor of Clinical Pharmacy
University of California San Diego
Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies

Click to view Dr. Abdul-Mutakabbir's biography
Dr. Jacinda Abdul-Mutakabbir completed her Doctorate in Pharmacy at the University of Saint Joseph School of Pharmacy, an accelerated three-year pharmacy program, located in Hartford, CT. Following pharmacy school, she completed her pharmacy residency at the Howard University Hospital in Washington, DC. She also completed an Infectious Disease Pharmacokinetics/ Pharmacodynamics (PK/PD) Research Fellowship under the tutelage of Dr. Michael J. Rybak PharmD, MPH, PhD, and went on to earn a Masters of Public Health at Wayne State University in Detroit, MI. As an emerging practitioner, her primary research interests include translating her in vitro research, focusing on multidrug-resistant bacteria, to improve patient treatment strategies in vivo. Her dedication to improving public health has been recognized by the United States Public Health Services, as she was the 2017 recipient of the USPHS Outstanding Service Award. Additionally, her research has led her to be recognized by the European Congress of Clinical Microbiology and Infectious Diseases one of their 30 under 30 outstanding young scientists, for their ECCMID 2021 31st annual meeting. In addition to Making a Difference in Infectious Diseases (MAD-ID), Dr. Abdul-Mutakabbir continues to be an active member of several professional organization including the American Academy of HIV Medicine (AAHIVM), Infectious Diseases Society of America (IDSA), American Society of Microbiology (ASM), and the Society of Infectious Disease Pharmacists (SIDP).

John A. Bosso, PharmD, FCCP, FIDSA, FIDP
Professor Emeritus
Department of Clinical Pharmacy
College of Pharmacy, Medical University of South Carolina, Charleston, SC
Professor of Medicine; Division of Infectious Disease
College of Medicine, Medical University of South Carolina, Charleston, SC

Click to view Dr. Bosso's biography
Dr. Bosso earned his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from the State University of New York at Buffalo. He is Professor Emeritus, Department of Clinical Pharmacy & Outcomes Sciences, College of Pharmacy,  and Professor Emeritus of Medicine in the Division of Infectious Diseases at the Medical University of South Carolina in Charleston, South Carolina. During his career, Dr. Bosso has served on the faculties of the University of Utah, Colleges of Pharmacy and Medicine and the University of Houston College of Pharmacy and Baylor College of Medicine, both in Houston, Texas. He participated in team-based clinical care in general pediatrics and adult infectious diseases during his years of clinical practice.

His research interests focus on anti-infective pharmacokinetics, pharmacodynamics, and efficacy in both pediatric and adult patients. Dr. Bosso has published over 140 peer-reviewed articles in journals such as Pharmacotherapy, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, The Pediatric Infectious Disease Journal, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, and The Journal of Infectious Diseases Pharmacotherapy. He has written chapters for textbooks that include Pharmacotherapy: A Pathophysiologic Approach, The Pharmacotherapy Self-Assessment Program, and The Textbook of Pediatric Infectious Diseases. He has served as a member of the editorial boards of Antimicrobial Agents and Chemotherapy, Pharmacotherapy, and The Journal of Pediatric Pharmacology and Therapeutics and if currently a Scientific Editor for Pharmacotherapy.

Dr. Bosso has been active in a number of professional organizations, and was a founding member and a past-president of the Society of Infectious Diseases Pharmacists, a founding member and current president of MAD-ID is a past-president of the American College of Clinical Pharmacy.

Eileen Carter, PhD, RN
Assistant Professor
University of Connecticut School of Nursing, Storrs, CT

Click to view Dr. Carter's biography
Dr. Carter earned her Bachelor of Science in Nursing at the New York University, School of Education and her Master of Philosophy in Nursing and Doctor of Philosophy in Nursing at Columbia University School of Nursing.

Dr. Carter received the Mary Fay Enrichment Award at Brigham and Women’s Hospital in 2009 and was named Jonas Nurse Leader Scholar at Columbia University School of Nursing 2012-2014. She has served on the National Institutes of Health, Healthcare Delivery and Methodologies, Special Emphasis Panel (July 2016) and the Centers for Disease Control and Prevention, Research on Technical Improvement of Personal Protective Equipment, Special Emphasis Panel (March 2016). Her research is funded by the Agency for Healthcare Research and Quality and she currently serves as co-investigator on two Agency grants. She recently served as a co-author on the CDC – American Nurses Association white paper entitled: Redefining the Antibiotic Stewardship Team: Recommendations from the American Nurses Association/Centers for Disease Control and Prevention Workgroup on the Role of Registered Nurses in Hospital Antibiotic Stewardship Practices.

Susan L. Davis, PharmD
Clinical Professor
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
Infectious Diseases Pharmacy Specialist
Henry Ford Hospital, Detroit, MI

Click to view Dr. Davis' biography
Dr. Davis is a Clinical Associate Professor of Pharmacy Practice at Wayne State University (WSU), with a joint appointment as an Infectious Diseases Pharmacy Specialist at Henry Ford Hospital (HFH) in Detroit. She graduated from the University of Michigan College of Pharmacy, completed her residency training at Detroit Receiving Hospital, and a fellowship in Infectious Diseases Outcomes Research at Wayne State University.
Her primary research interests include strategies to improve outcomes of infectious diseases with a focus on antimicrobial stewardship and multidrug resistant bacteria. Her practice, teaching and research have been recognized with the Society of Infectious Disease Pharmacists Outstanding Clinical Practice award, the American Society of Health System Pharmacists Foundation New Preceptor of the Year award, and the Wayne State University College of Pharmacy and Health Sciences Research Excellence Award. She is a board member-at-large of SIDP and has been active in MAD-ID for over 10 years.

Thomas M. File Jr., MD
Chief of the Infectious Disease Service and Director of HIV Research, Summa Health System
Professor of Internal Medicine and Master Teacher
Northeastern Ohio Universities College of Medicine, Rootstown, Ohio

Click to view Dr. File's biography

Dr Thomas File is Chair of the Infectious Disease Division and Co-Director of Antimicrobial Stewardship at Summa Health in Akron, Ohio and Professor of Internal Medicine, Master Teacher, and Chair of the Infectious Disease Section at Northeast Ohio Medical University. After graduating from medical school at the University of Michigan, Ann Arbor, in 1972, Dr. File received his Master of Science in medical microbiology from Ohio State University in Columbus, in 1977, where he also completed his fellowship in infectious diseases.

Dr File is a past President of the Board of Directors of the Infectious Diseases Society of America (IDSA) and Past President of the National Foundation for Infectious Diseases (NFID).  He is a Master of the American College of Physicians, a fellow of the American College of Chest Physicians, and a member of the American Thoracic Society.  He is a past Chairperson of the Standards and Practice Guidelines Committee of the IDSA and served as a member of several guideline panels.  He is a past-president of the Infectious Disease Society of Ohio.

Primary research interests that Dr File has pursued include respiratory tract infections, antimicrobial stewardship, immunizations in adults, and evaluation of new antimicrobial agents. A frequent lecturer nationally and internationally, he has published more than 250 articles, abstracts, and textbook chapters, focusing on the diagnosis, etiology, and treatment of infectious diseases, especially on respiratory tract infections and antimicrobial stewardship. He received the Watanakunakorn Clinician Award from the IDSA in 2013 and the John P Utz Leadership award from NFID in May 2017. He authors sections on community-acquired pneumonia, acute bronchitis, and hospital-acquired pneumonia in UpToDate.  He is Editor-in-Chief of Infectious Diseases in Clinical Practice.


Debra A. Goff, PharmD, FCCP
Infectious Disease Specialist
Clinical Associate Professor
The Ohio State University Medical Center, Columbus, OH

Click to view Dr. Goff's biography

Debra Goff is an Infectious Disease Specialist and founding member of the Antimicrobial Stewardship Program at The Ohio State University Wexner Medical Center (OSUWMC) in Columbus Ohio. She is the past-Director of the Infectious Diseases Residency program at OSUWMC and an Associate Professor at the College of Pharmacy working with the One Health Antibiotic Stewardship team at OSU. Dr. Goff received her Bachelor of Pharmacy and Doctor of Pharmacy degrees from the University of Illinois at Chicago, where she also completed her residency.

Dr. Goff is a 2016 TEDx Columbus speaker on antibiotics “just in case” there’s infection with over 16,500 views on YouTube. She is the international advisor to the Federation of Infectious Diseases Society of South Africa (FIDSSA) mentoring South African pharmacists. She received the 2016 OSU Emerging International Outreach and Engagement Award and the 2019 Distinguished International Outreach and Engagement Award for her work in South Africa. She is the 2017 American College of Clinical Pharmacy (ACCP) recipient of the Global Health Award. She serves as a faculty mentor to young African leaders as part of the Mandela Washington Fellowship Program. Dr. Goff is a faculty member of the World Health Organization (WHO) developing an antimicrobial stewardship toolkit for low middle income countries. She uses Twitter to engage, connect, and educate her 6,000 followers from multiple countries on issues related to antimicrobial resistance and stewardship.

Her interests include antimicrobial resistance, the application of rapid diagnostic tests with stewardship interventions, use of Twitter to increase global engagement and patient advocate organizations in antibiotic stewardship. She lectures nationally and internationally as an antimicrobial stewardship advocate.

Chief, Division of Allergy, Immunology and Infectious Diseases
Professor of Medicine
Department of Medicine at Rutgers Wood Johnson Medical School, New Brunswick, NJ

Click to view Dr. Kaye's biography

Dr. Kaye is the Chief, Division of Allergy, Immunology and Infectious Diseases, and is Professor of Medicine in the Department of Medicine at Rutgers Robert Wood Johnson Medical School.

He has devoted his career to the prevention and effective management of healthcare-associated infections. In addition to serving in a variety of quality improvement and administrative roles in infection prevention, antimicrobial stewardship, and quality and patient safety, he has served on national and international clinical guidelines committees.

Dr. Kaye’s research interests include prevention and treatment of antimicrobial resistant organisms, prevention of healthcare associated infections, and innovative approaches to antimicrobial stewardship.  He has a long and productive track record of federal funding for research pertaining to management and prevention of multi-drug resistant organisms and healthcare associated infections, including groundbreaking clinical trials.

Dr. Kaye received his medical degree from the University of Pennsylvania and completed his Internal Medicine residency and Infectious Diseases fellowship at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 350 peer-reviewed articles and 20 book chapters and has frequently presented original research at national and international conferences. Dr. Kaye is a past President of the Society for Health Epidemiology of America (SHEA). He is an internationally recognized expert in healthcare epidemiology and antimicrobial resistance and has been invited to speak on these topics at venues throughout the world.

Kerry L. LaPlante, PharmD., FCCP, FIDSA
Professor of Pharmacy, University of Rhode Island, Kingston, RI
Adjunct Professor of Medicine, Brown University, Providence, RI

Click to view Dr. LaPlante's biography

Kerry LaPlante, Pharm.D., FCCP is a tenured Professor of Pharmacy at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, and the Founding Director of the Antimicrobial Stewardship Research Fellowship at the Providence Veterans Medical Center. Her work is dedicated to furthering antibiotic education and research across the full spectrum of healthcare science, from antibiotic development to clinical applications. An underlying hypothesis in Dr. LaPlante’s research is that implementing positive change in prescriber habits will occur through communication, trust, personalized education, and highlighting the safety and public health benefit to their patients and their local community. Most recently, her research has focused on the development of public health messaging and trust in desperate patient populations, along with implementing antimicrobial stewardship programs in acute care, and long-term care patient populations across the VA nationally.

Dr. LaPlante’s clinical and research career has been focused on identifying effective and safe treatments for antimicrobial resistance pathogens and, more specifically on the impact that antimicrobial prescribing and stewardship has on the emergence and spread of antimicrobial resistance. Dr. LaPlante also directs active in vitro research program (BSL-2) that explores pharmacodynamic dosing indexes of combination antibiotic therapy in pathogenic bacteria, specifically the treatment, virulence inhibition (toxin and biofilm), colonization and control of multiply drug resistant pathogens in catheter lock solutions.

Dr. LaPlante has maintained continuous uninterrupted funding for her in vitro and outcomes research program from both public and private sources since arriving at the university in 2004. Her award-funding total is over 12 million from agencies such as National Institutes of Health, Department of Veterans Affairs, and Investigator Initiated Research at Pfizer, Merck and other Research and Development based pharmaceutical companies.

An internationally recognized leader in the field of antibiotic research, Dr. LaPlante is an elected Fellow of the American College of Clinical Pharmacy, and president-elect of the Society of Infectious Diseases Pharmacists, and appointed Vice-Chairperson of the Rhode Island Department of Health Antimicrobial Stewardship and Environmental Cleaning Task Force, and has served on the editorial boards for the leading journals in pharmacy and pathogenic microbiology (including Pharmacotherapy and Virulence). She is also the recipient of the Rhode Island Society of Health-System Pharmacists, 2016 Pharmacist of the Year and the Society of Infectious Diseases Pharmacist Researcher of the year 2010. She is frequently invited to lecture at national infectious diseases meetings and symposia, and is an author on over 80 peer-reviewed articles, and book chapters, which span topics from antimicrobial stewardship, antibiotic resistance, drug discovery and in vitro activity of combination antimicrobial agents. She is also the senior editor of a book titled “Antimicrobial Stewardship Principles and Practices” which is currently in press and available at Amazon.

Kenneth Lawrence, PharmD
Senior Medical Director, Medical Affairs
Seres Therapeutics, Cambridge, MA

Click to view Dr. Lawrences's biography
Kenneth Lawrence, BS, PharmD is currently Senior Medical Director, Medical Affairs at Seres Therapeutics. Is a graduate of the University of Rhode Island for both his Bachelor of Pharmacy and Doctor of Pharmacy Degree’s. Dr. Lawrence began his 20-year clinical pharmacy practice career as a critical care pharmacist later transitioning to Infectious Disease/Antimicrobial Stewardship. More recently, he has held roles in Clinical Development and most recently Medical Affairs. For the past decade, his work has been dedicated to expanding the pipeline antimicrobial drugs for the treatment of challenging pathogens. He is passionate about antimicrobial development and incorporating antimicrobial stewardship strategies into Medical Affairs to partner with health systems and patient advocacy groups to improve patient care. Additionally, he is working with area high schools and pharmaceutical companies to highlight the need and benefit of encouraging more students from underrepresented minority groups to choose careers in STEM.

Jason Newland, MD, EdD
Associate Professor of Pediatrics
Washington University School of Medicine in St. Louis, MO

Click to view Dr. Newland's biography

Dr. Newland grew up in southwest Oklahoma and obtained his B.S. in Pre-professional studies at the University of Notre Dame in 1996 and medical degree from the University of Oklahoma College of Medicine in 2000. He completed pediatric residency at the University of Nebraska/Creighton Medical Centers in 2003 and fellowship in Pediatric infectious diseases at the Children’s Hospital of Philadelphia in 2006, distinguishing himself with teaching awards at both the resident and fellow level.

In August of 2006, he joined the faculty at Children’s Mercy Hospitals & Clinics in Kansas City, Missouri where he was the director of the antimicrobial stewardship program and the director of evidence-based practice. An active resident and faculty mentor, he has also completed his master’s in education through a joint program offered by the Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Education, focusing on adult learning, curriculum and teaching methods, and medical education evaluation and research. Since 2016, he has been a Professor of Pediatrics at Washington University School of Medicine in St. Louis.

His current research spotlights the use of antimicrobials and the impact of an antimicrobial stewardship program at a children’s hospital.  He is a co-founder of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative for improving antimicrobial use in children that is comprised of over 60 Children’s Hospitals in the United States. Additionally, he has been involved in the evaluation of COVID-19 testing and transmission in schools.

Michael J. Rybak, PharmD, MPH, PhD, FCCP
Associate Dean for Research
Professor of Pharmacy and Medicine
Director, Anti-Infective Research Laboratory
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI

Click to view Dr. Rybak's biography

Michael J. Rybak, Pharm.D., M.P.H., PH.D. is a Professor of Pharmacy, Department of Pharmacy Practice, adjunct Professor of Pharmaceutical Sciences and Director, Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University.  He is also an adjunct Professor of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University and adjunct Professor of Pharmacy-Clinical, College of Pharmacy, University of Michigan.

Over the course of a long and distinguished career at Wayne State University, he has held several important posts, including serving for nearly 33 years as the Director for the Research Fellowship Program in Infectious Diseases Pharmacotherapy and Health Outcomes as well as the Associate Dean for Research at the Eugene Applebaum College of Pharmacy and Health Sciences, Chair and member of the University’s Human Investigation Committee, the College of Pharmacy and Health Science’s research committee and Wayne State University’s Clinical Translational Research Committee.

Dr. Rybak’s primary focus of research is antimicrobial pharmacokinetics and pharmacodynamics (PK/PD) and the assessment of infectious diseases health outcomes including their relationship to bacterial resistance.  His work is focused on the laboratory and clinical outcomes assessment of combination therapy for methicillin and vancomycin-resistant Staphylococcus aureus, enterococcus and multi-drug resistant gram-negative pathogens. Currently his laboratory is exploring the role of combination bacteriophage and antibiotics for the treatment of multi-drug resistant pathogens.  Dr. Rybak is currently funded by the National Institute for Allergy and Infectious Diseases (NIAID), the and via several investigator initiated grants from Pharmaceutical industry. He has published more than 380 manuscripts in medical and scientific journals and authored 20 book chapters on antimicrobial PKPD, resistance and antimicrobial stewardship. He is the editor-in-chief of the journal Infectious Diseases and Therapyand a scientific editor for Infectious Diseases for Pharmacotherapy,editorial board member for Critical Reviews in Microbiology.  He is a reviewer for several leading publications including Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases and Lancet ID.

 Dr. Rybak is one of the founding members, past president and fellow of the Society of Infectious Diseases Pharmacists and has held key positions at the American College of Clinical Pharmacy and the American Society of Health-Systems Pharmacists. He is a member and fellow of the Infectious Diseases Society of America and has served on key Infectious Diseases Guidelines Committees such as the MRSA guidelines committee for Infectious Diseases Society of America, the American Heart Association’s Infective Endocarditis guidelines and the Vancomycin Consensus Guidelines committee (chair).

Edward J. Septimus, MD, FIDSA, FACP, FSHEA
Clinical Professor
Texas A&M Medical School, Houston, TX

Click to view Dr. Septimus' biography

Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972.  Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases.

He was VP Research and Infectious Diseases HCA Healthcare until 2018.  Prior to HCA, he was the medical director of infectious diseases and occupational health for Memorial Hermann Healthcare System. He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and was on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee.   He was the first recipient of the IDSA Watanakunakorn Clinician Award.  In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services.  He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013 and 2014.  He was on the FDA Anti-Infective Drug Advisory Group and was co-chair of the NQF Patient Safety Steering Committee until end of 2021.

He holds a faculty position as Adjunct Professor at Texas A&M College of Medicine, Senior Lecturer Department of Population Medicine Harvard Medical School, and Adjunct Professor of Medicine Houston Methodist Research Institute/WeillCornell.  He has published over 140 articles and chapters.